Immutep Shares Jump 13% on Lung-Cancer Combination Trial Data
By Stuart Condie SYDNEY--Immutep shares are on course for their best day since June after the Australia-listed developer of cancer treatments presented...
Source: marketwatch.com
Stay updated with breaking news from Imm Au. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Stuart Condie SYDNEY--Immutep shares are on course for their best day since June after the Australia-listed developer of cancer treatments presented...